Intracellular Pharmacokinetics of Once versus Twice Daily Zidovudine and Lamivudine in Adolescents
Patricia M. Flynn(St. Jude Children's Research Hospital), Jaime Martinez(John H. Stroger, Jr. Hospital of Cook County), Jack Rodman(Boston University), José F. Rodrígúez(Consejo Superior de Investigaciones Científicas), Katherine M. Knapp(St. Jude Children's Research Hospital), Edmund V. Capparelli(University of California San Diego), Leslie Serchuck, Brian L. Robbins(University of North Carolina at Chapel Hill), James McNamara(National Institute of Allergy and Infectious Diseases), Barbara Heckman(Frontier Science & Technology Research Foundation, Inc.), Jane C. Lindsey(Harvard University Press)
Cited by 25
Related Papers
Clinical Practice Guidelines for the Diagnosis and Management of Intravascular Catheter-Related Infection: 2009 Update by the Infectious Diseases Society of America
|Clinical Infectious Diseases|2009|3.6k
Maternal Viral Load, Zidovudine Treatment, and the Risk of Transmission of Human Immunodeficiency Virus Type 1 from Mother to Infant
|New England Journal of Medicine|1996|817
MRP4: A previously unidentified factor in resistance to nucleoside-based antiviral drugs
|Nature Medicine|1999|580
Benefits and Risks of Antiretroviral Therapy for Perinatal HIV Prevention
|New England Journal of Medicine|2016|348